IBM
46
3
CMI
49
-2
AEE
53
2
GS
59
-4
PX
63
-6
GRMN
70
-4
C
55
-2
YUM
36
-3
CMCSA
53
5
COP
56
9
STI
66
-7
ADT
48
-3
EXC
37
-3
DTE
47
-2
ICE
56
-11
MA
55
-9
ABBV
62
3
ADSK
61
-2
ZBH
56
-6
PRU
54
-8
IBM
46
3
CMI
49
-2
AEE
53
2
GS
59
-4
PX
63
-6
GRMN
70
-4
C
55
-2
YUM
36
-3
CMCSA
53
5
COP
56
9
STI
66
-7
ADT
48
-3
EXC
37
-3
DTE
47
-2
ICE
56
-11
MA
55
-9
ABBV
62
3
ADSK
61
-2
ZBH
56
-6
PRU
54
-8
Financhill
Back

Matthews Emerging Markets Ex Chn Act ETF Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
48

MEMX
Matthews Emerging Markets Ex Chn Act ETF

Last Price:
30.28
Seasonality Move:
8.81%
Buy
71

MDGL
Madrigal Pharmaceuticals

Last Price:
312.62
Seasonality Move:
31.67%
Sell
48
Matthews Emerging Markets Ex Chn Act ETF (MEMX) is a Sell

Is Matthews Emerging Markets Ex Chn Act ETF a Buy, Sell or Hold?

  • The current Matthews Emerging Markets Ex Chn Act ETF [MEMX] share price is $30.06. The Score for MEMX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • MEMX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MEMX Stock Price Chart

What is Matthews Emerging Markets Ex Chn Act ETF's stock price today?

  • The Matthews Emerging Markets Ex Chn Act ETF share price today is $30.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEMX is experiencing slight buying pressure.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $259.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

MEMX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 36.46 Sell
Chaikin Money Flow: 816 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.38 - 30.84) Sell
Bollinger Bands (100): (29.76 - 30.96) Sell

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 74.74 Buy
Chaikin Money Flow: 898979 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.29 - 223.91) Buy
Bollinger Bands (100): (221.8 - 277.54) Buy

MEMX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.53 Sell
20-day SMA: 30.58 Sell
50-day SMA: 30.6 Sell
200-day SMA: 29.48 Buy
8-day EMA: 30.47 Sell
20-day EMA: 30.58 Sell
50-day EMA: 30.52 Sell
200-day EMA: 29.46 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 216.22 Buy
20-day SMA: 214.16 Buy
50-day SMA: 227.04 Buy
200-day SMA: 240.71 Buy
8-day EMA: 223.2 Buy
20-day EMA: 218.42 Buy
50-day EMA: 226.38 Buy
200-day EMA: 233.63 Buy

Matthews Emerging Markets Ex Chn Act ETF Earnings Growth & MEMX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.

Matthews Emerging Markets Ex Chn Act ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):